IJCM  Vol.9 No.3 , March 2018
Renal Replacement Therapy in a Caribbean Population: The Impact of Biological, Sociocultural and Demographic Factors
Abstract: Background: The options for renal replacement therapy for end stage renal disease include haemodialysis (HD), peritoneal dialysis (PD) and renal transplantation. In this study demographic, sociocultural and biological factors were assessed over a 1-year period for patients on renal replacement therapy. Methods: This cross-sectional study included all patients 18 years and older and on renal replacement therapy for at least 3 months in Trinidad and Tobago. Five hundred and thirty participants were recruited from our organ transplantation unit, all centres facilitating PD and a stratified random sample of all HD centres (100 T, 80 PD, 350 HD from October 2015 to October 2016. A questionnaire was administered and included demographics, knowledge and understanding and biological factors impacting on renal replacement therapy. Results: Thirty eight percent of all patients were between 56 to 65 years of age. The Indo Trinidadian population accounted for 51% of the subjects. 52.5% were male and 47.5% were female. From the data, 72% of patients were diabetic and/or hypertensive. In the transplant recipients, 39% were diabetic and/or hypertensive and 27% reported chronic glomerulonephritis as the aetiology of their kidney failure. The diagnosis of chronic kidney disease was made when patients were at end stage renal disease requiring intervention in 84.2% of persons. The employed population of patients constituted 65% of renal transplant recipients, 43.75% of peritoneal dialysis patients and 22.86% of haemodialysis patients. The patient’s physician had the greatest influence on renal replacement therapy choice (85.4% haemodialysis, 85% peritoneal dialysis, 71% transplant). Conclusions: In this cohort of 530 patients on renal replacement therapy, knowledge of therapy and physician’s influence were some of the factors that impacted on choice of therapy. Most patients were already de novo end stage renal disease when the diagnosis of kidney disease was made. Life diseases-type 2 diabetes mellitus and hypertension were the main causative diseases contributing to renal failure. This study which is the first in the Caribbean to evaluate biological, sociocultural and demographic factors in patients receiving renal replacement will better assist in prevention strategies and resource allocation.
Cite this paper: Sanchez, S. , Rampersad, A. , Jagdeo, C. , Ayuen, P. , Gunness, C. and Legall, G. (2018) Renal Replacement Therapy in a Caribbean Population: The Impact of Biological, Sociocultural and Demographic Factors. International Journal of Clinical Medicine, 9, 142-161. doi: 10.4236/ijcm.2018.93013.

[1]   Liem, Y.S., Bosch, J.L. and Arends, L.R. (2007) Quality of Life Assessed with the Medical Outcomes Study Short-Form 36-Item Health Survey of Patients on Renal Replacement Therapy: A Systematic Review and Metaanalysis. Value in Health, 10, 390-397. 00193.x

[2]   Cameron, J.I., Whiteside, C., Katz, J. and Devins, G.M. (2000) Differences in Quality of Life across Renal Replacement Therapies: A Meta-Analytic Comparison. American Journal of Kidney Disease, 35, 629-637.

[3]   Makkar, V., Kumar, M., Mahajan, R. and Khaira, N.S. (2015) Comparison of Outcomes and Quality of Life between Hemodialysis and Peritoneal Dialysis Patients in Indian ESRD Population. Journal of Clinical and Diagnostic Research, 9, 28-31.

[4]   Mendes de Abreu, M., Walker, D.R., Sesso, R.C. and Ferraz, M.B. (2011) Health-Related Quality of Life of Patients Receiving Hemodialysis and Peritoneal Dialysis in São Paulo, Brazil: A Longitudinal Study. Value in Health, 13, 191-211.

[5]   García-Llana, H., Remor, E. and Sagas, R. (2013) Adherence to Treatment, Emotional State and Quality of Life in Patients with End-Stage Renal Disease Undergoing Dialysis. Psicothema, 25, 79-86.

[6]   Bakewell, A.B., Higgins, R.M. and Edmunds, M.E. (2002) Quality of Life in Peritoneal Dialysis Patients: Decline over Time and Association with Clinical Outcomes. Kidney International Journal, 61, 239-248.

[7]   Khan, S., Bisnath, R., Jaipaul, J., Doodhai, J., Ramlal, D., et al. (2015) Screening for Chronic Kidney Disease in East Trinidad Using the National Kidney Foundation Guidelines. West Indian Medical Journal Supplement, 1-75.

[8]   Fiebiger, W., Mitterbauer, C. and Oberbauer, R. (2004) Health-Related Quality of Life Outcomes after Kidney Transplantation. Health Related Quality of Life Outcomes, 2, 2.

[9]   Alvares, J., Cesar, C.C., Acurcio Fde, A., Andrade, E.I. and Cherchiglia, M.L. (2012) Quality of Life of Patients on Renal Replacement Therapy in Brazil: Comparison of Treatment Modalities. Quality of Life Research Journal, 21, 983-991.

[10]   Laupacis, A., Keown, P., Pus, N., Krueger, H., Ferguson, B., Wong, C. and Muirhead, N. (1996) A Study of the Quality of Life and Cost Utility of Renal Transplantation. Kidney International Journal, 50, 235-242.

[11]   Oliveira de Mendonça, A.E., Torres, G., Salvetti, M., Alchieri, J.C. and Fernandes Costa, I.K. (2014) Changes in Quality of Life after Kidney Transplantation and Related Factors. Acta Paulista de Enfermagem, 27, 287-292.

[12]   Eduardo, N., Rodrigues, R. and Barata, C. (2015) Dyadic Relationship and Quality of Life of Patients with Chronic Kidney Disease. Brazilian Journal of Nephrology, 37, 315-322.

[13]   Liem, Y.S., Bosch, J.L. and Hunink, M.G. (2008) Preference Based Quality of Life of Patients on Renal Replacement Therapy: A Systematic Review and Meta-Analysis. Value in Health, 11, 733-741.

[14]   Panagopoulou, A., Hardalias, A., Berati, S. and Fourtounas, C. (2009) Psychosocial Issues and Quality of Life in Patients on Renal Replacement Therapy. Saudi Journal of Kidney Disease and Transplantation, 20, 212-218.

[15]   Valderrabano, F., Jofre, R. and Lopez-Gomez, J.M. (2001) Quality of Life in End Stage Renal Disease Patients. American Journal of Kidney Disease, 38, 443-464.

[16]   Sayin, A., Mutluay, R. and Sindel, S. (2007) Quality of Life in Haemodialysis, Peritoneal Dialysis and Transplantation Patients. Transplant Proceedings, 39, 3047-3053.

[17]   Soyibo, A.K. and Barton, E.N. (2007) Report from the Caribbean Renal Registry. West Indian Medical Journal, 56, 355.

[18]   The National Organ Transplant Unit of Trinidad and Tobago (2016) Eric Williams Medical Sciences Complex, Mt Hope, Trinidad, West Indies.

[19]   Roberts, L., Ramsaroop, K. and Seemungal, T. (2012) Survival Outcomes in Renal Transplantation in Trinidad and Tobago: SORTTT Study. West Indian Medical Journal, 61, 422-428.

[20]   National Kidney Foundation (2002) KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification.

[21]   International Standard Classification of Occupations of the United Nations. ISCO 08.

[22]   World Health Organization (2008) Global Database on Body Mass Index: An Interactive Surveillance Tool for Monitoring Nutrition Transition.

[23]   World Health Organization (2012) International Classification of Diseases and Related Health Problems. ICD 10, 1-201.

[24]   Tillin, T., Sattar, N., Godsland, I.F., Hughes, A.D., Chaturvedi, N., et al. (2015) Ethnicity Specific Obesity Cut-Points in the Development of Type 2 Diabetes Mellitus—A Prospective Study Including Three Ethnic Groups in the United Kingdom. Diabetic Medicine, 32, 226-234.

[25]   Robinson, B.M., Akizawa, T., Jager, K.I., Kerr, P.G., Saran, R., et al. (2016) Factors Affecting Outcomes in Patients Reaching End Stage Kidney Disease Worldwide: Differences in Access to Renal Replacement Therapy, Modality Use, and Haemodialysis Practices. Lancet, 388, 294-306.

[26]   Gerasimoula, K., Lefkothea, L., Maria, L., Victoria, A., Paraskevc, T., et al. (2015) Quality of Life in Haemodialysis Patients. Materia Sociomedica, 27, 305-309.

[27]   Chen, M.C., Tsai, W.L., Tsai, I.C., Chan, S.W., Liao, W.C., et al. (2010) Arteriovenous Fistula and Graft Evaluation in Hemodialysis Patients Using MDCT: A Primer. American Journal of Roentgenology, 194, 838-847.

[28]   Wasse, H., Kutner, N., Zhang, R. and Huang, Y. (2007) Association of Initial HD Vascular Access with Patient Reported Health Status and Quality of Life. Clinical Journal of the American Society of Nephrology, 2, 708-771.

[29]   Mohamed-Ali, V., Goodrick, S., Bulmer, K., Holly, J.M., Yudkin, J.S., et al. (1999) Production of Soluble Tumor Necrosis Factor Receptors by Human Subcutaneous Adipose Tissue In Vivo. American Journal of Physiology, 277, E971-E975.

[30]   Demas, G.E., Drazen, D.L. and Nelson, R.J. (2003) Reductions in Total Body Fat Decrease Humoral Immunity. Proceedings of the Royal Society Biological Sciences, 270, 905-911.

[31]   Beddhu, S. (2004) The Body Mass Index Paradox and an Obesity, Inflammation, and Atherosclerosis Syndrome in Chronic Kidney Disease. Seminar in Dialysis Journal, 17, 229-232.

[32]   Kalantar-Zadeh, K., Abbott, K.C., Salahudeen, A.K., Kilpatrick, R.D. and Horwich, T.B. (2005) Survival Advantages of Obesity in Dialysis Patients. The American Journal of Clinical Nutrition, 81, 543-54.

[33]   Ikizler, T.A. (2008) Resolved: Being fat is good for dialysis patients: The Godzilla Effect. Journal of the American Society of Nephrology, 19, 1059-1064.

[34]   Fadem, S.Z., Walker, D.R., Abott, G., Friedman, A.L., Goldman, R., et al. (2011) Satisfaction with Renal Replacement Therapy and Education: The American Association of Kidney Patients Survey. Clinical Journal of the American Society of Nephrology, 6, 605-612.

[35]   Mehrotra, R., Marsh, D., Vonesh, E., Peters, V. and Nissenson, A. (2005) Patient Education and Access of ESRD Patients to Renal Replacement Therapies beyond In-Center Hemodialysis. Kidney International Journal, 68, 378-390. 00453.x

[36]   United States Renal Data System (1997) The USRDS Dialysis Morbidity and Mortality Study: Wave 2. American Journal of Kidney Disease, 30, S67-S85.

[37]   Finkelstein, F.O., Story, K., Firanek, C., Barre, P., Takano, T., et al. (2008) Perceived Knowledge among Patients Cared for by Nephrologists about Chronic Kidney Disease and End-Stage Renal Disease Therapies. Kidney International Journal, 74, 1178-1184.

[38]   Morton, R.L., Tong, A., Howard, K., Snelling, P. and Webster, A.C. (2010) The Views of Patients and Careers in Treatment Decision Making for Chronic Kidney Disease: Systematic Review and Thematic Synthesis of Qualitative Studies. British Medical Journal, 340, c112.

[39]   Givens, R. (2016) The United Network for Organ Sharing (UNOS).

[40]   Rabbat, C.G., Thorpe, K.E., Russell, J.D. and Churchill, D.N. (2000) Comparison of Mortality Risk for Dialysis Patients and Cadaveric First Renal Transplant Recipients in Ontario, Canada. Clinical Journal of the American Society of Nephrology, 11, 5917-5922.

[41]   Don, Y.K., Tammy, K.C., Myoung-Hee, K., Junhyug, N., Gunhee, K., et al. (2016) Superior Outcomes of Kidney Transplantation Compared with Dialysis: An Optimal Matched Analysis of a National Population-Based Cohort Study between 2005 and 2008 in Korea. Medicine, 95, e4352.